Sana Biotechnology to present SG293 preclinical data at gene therapy meeting

April 27, 2026 4:30 PM

Sana Biotechnology Inc. (NASDAQ: SANA) announced that preclinical data from its CD19-directed in vivo CAR T product candidate SG293 will ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found